Intravenous cyclophosphamide<i>vs</i>rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
N
Shared by NobleBlocks on Jul 26, 2018 • 12:00 AM UTC
Authors:
Geetabali Sircar
,
Rudra Prosad Goswami
,
Dipankar Sircar
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Intravenous cyclophosphamide<i>vs</i>rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial | NobleBlocks
